You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


Advertisement

ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | RSS | Access Rights | Sign In


  Vol. 161 No. 1, January 8, 2001 TABLE OF CONTENTS
  Online Only
 •  Online First Table of
Contents
  Comments, Opinions, and Brief Case Reports
 •Online Features
 This Article
 •Full text
 •PDF
 • Reply to article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (9)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Delicious Add to Digg Add to Facebook Add to Reddit Add to Technorati Add to Twitter What's this?

Systematic Reviews Neglect Safety Issues

Arch Intern Med. 2001;161:125-126.

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

The concept of evidence-based medicine is as simple as it is compelling and has indisputably had a major influence on modern therapeutics. Evidence-based medicine aims to objectively evaluate all medical interventions with a view of translating this knowledge into routine medical practice and thus enhancing patient care. One of its most powerful tools to achieve this aim is the systematic review (SR).1 Systematic reviews, including meta-analyses, aim at impartially assessing the evidence for a given treatment and usually focus on efficacy or effectiveness. Yet safety data are equally important for evidence-based decisions about the value (or otherwise) of therapeutic interventions.

To determine to what extent safety issues have been the subject of SRs, the literature was searched using MEDLINE (1966 to November 1999). The search terms were "systematic review," "meta-analysis," "efficacy," "effectiveness," "safety," "adverse effects," "adverse reactions," and derivatives of these terms. Identified articles were categorized according to the time . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Delicious Delicious   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Comprehensive evaluations of the adverse effects of drugs: importance of appropriate study selection and data sources
Loke et al.
Therapeutic Advances in Drug Safety 2011;2:59-68.
ABSTRACT  

Characteristics of Published Comparative Effectiveness Studies of Medications
Hochman and McCormick
JAMA 2010;303:951-958.
ABSTRACT | FULL TEXT  

Neutropenia due to clopidogrel in a patient with end-stage renal disease
Akcay et al.
The Annals of Pharmacotherapy 2004;38:1538-1539.
FULL TEXT  

Clopidogrel-Associated Leukopenia
McCarthy and Kockler
The Annals of Pharmacotherapy 2003;37:216-219.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | PHYSICIAN JOBS | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2001 American Medical Association. All Rights Reserved.